David Hickey - 26 Nov 2023 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Role: EVP & President, Life Sciences
Signature: Donna Kalazdy, by power of attorney for David Hickey
Issuer symbol: BDX
Transactions as of: 26 Nov 2023
Net transactions value: $0
Form type: 4
Filing time: 28 Nov 2023, 20:24:34 UTC
Previous filing: 14 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDX	Common Stock	Award	$0	+1,663	+40%	$0.000000	5,862	26 Nov 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BDX	Stock Appreciation Rights	Award	$0	+9,213		$0.000000	9,213	26 Nov 2023	Common Stock	9,213	$238.89	Direct	F2
transaction	BDX	Rights to Common Stock Under Deferred Compensation Plan	Award	$0	+3,024	+33%	$0.000000	12,237	26 Nov 2023	Common Stock	3,024	$238.89	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2	The stock appreciation rights vest in four annual installments beginning November 26, 2024.
F3	The securities are distributed following termination of the reporting person's employment or on the date or dates specified by the reporting person.